Inhibition of matrix degrading enzymes and invasion in human glioblastoma (U87MG) cells by isoflavones

Journal of Neuro-Oncology

Volumn 79, Issue 2, 2006, Pages 135-142

  Puli, Shilpa ^a   Lai, James C K ^a   Bhushan, Alok ^a  

^a IDAHO STATE UNIVERSITY   (United States)

Author keywords

Glioblastoma; Invasion; Isoflavones; MMPs; uPAR

Indexed keywords

BIOCHANIN A; EPIDERMAL GROWTH FACTOR; GELATINASE A; GELATINASE B; GENISTEIN; ISOFLAVONE DERIVATIVE; MATRIX METALLOPROTEINASE 14; PHYTOESTROGEN; SCLEROPROTEIN; UROKINASE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INVASION; CELL ASSAY; CELL MIGRATION; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; UPREGULATION;

BRAIN NEOPLASMS; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ENZYME INHIBITORS; ENZYME PRECURSORS; EPIDERMAL GROWTH FACTOR; EXTRACELLULAR MATRIX; GENISTEIN; GLIOBLASTOMA; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; NEOPLASM INVASIVENESS; RECEPTORS, CELL SURFACE;

EID: 33748453503     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-006-9126-0     Document Type: Article

References (60)

1. Central Brain Tumor Registry of the Unites States. Statistical report: primary brain tumors in the Unites States, 1995-1999. CBTRUS; 2002-2003
2. Kufe DW, Pollock RE, Weichselbaum RR, Bast RC, Gansler TS, Holland JF, Frei E: Cancer Medicine 6. BC Decker, New York, 2003, p1195-1231
3. Jeffrey Bruce: Glioblastoma Multiforme. eMedicine February, 2005
4. Tremont-Lukats IW, Gilbert MR: Advances in molecular therapies in patients with brain tumors Cancer Control 10(2): 125-37, 2003
5. Bello L, Giussani C, Carrabba G, Pluderi M, Costa F, Bikfalvi A: Angiogenesis and invasion in gliomas Cancer Treat Res 117:263-284, 2004
6. Binder DK, Berger MS: Proteases and the biology of glioma invasion J Neurooncol 56(2):149-158, 2002
7. Visse R, Nagase H: Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry Circ Res 92(8):827-839, 2003
8. Vihinen P, Kahari VM: Matrix mePalloproteinases in cancer: prognostic markers and therapeutic targets Int J Cancer 99(2):157-166, 2002
9. Kachra Z, Beaulieu E, Delbecchi L, Mousseau N, Berthelet F, Moumdjian R, Del Maestro R, Beliveau R: Expression of matrix metalloproteinases and their inhibitors in human brain tumors Clin Exp Metastasis 17(7):555-566, 1999
10. Deryugina EI, Bourdon MA, Luo GX, Reisfeld RA, Strongin A: Matrix metalloproteinase-2 activation modulates glioma cell migration J Cell Sci 110(19):2473-2482, 1997
11. Choe G, Park JK, Jouben-Steele L, Kremen TJ, Liau LM, Vinters HV, Cloughesy TF, Mischel PS: Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype Clin Cancer Res 8(9):2894-2901, 2002
12. Lampert K, Machein U, Machein MR, Conca W, Peter HH, Volk B: Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors Am J Pathol 153(2):429-437, 1998
13. Abe T, Mori T, Kohno K, Seiki M, Hayakawa T, Welgus HG, Hori S, Kuwano M: Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells Clin Exp Metastasis 12(4):296-304, 1994
14. Fillmore HL, VanMeter TE, Broaddus WC: Membrane-type matrix metalloproteinases (MT-MMPs): Expression and function during glioma invasion J Neurooncol 53(2):187-202, 2001
15. Hess AR, Seftor EA, Seftor RE, Hendrix MJ: Phosphoinositide 3-kinase regulates membrane Type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry Cancer Res 63(16):4757-4762, 2003
16. Ouyang YW, Peng ZL, Yao XY, Liu SL, He YD: The expression of matrix metalloproteinase-2 and -9 in cervical cancer and a study of their relationship Sichuan Da Xue Xue Bao Yi Xue Ban 35(3):330-333, 2004
17. Gurevich LE: Role of matrix metalloproteinases 2 and 9 in determination of invasive potential of pancreatic tumors. Bull Exp Biol Med 136(5):494-498, 2003
18. Fan SQ, Wei QY, Li MR, Zhang LQ, Liang QC: Expression and clinical significance of MMP-2, MMP-9, TIMP-1, and TIMP-2 in breast carcinoma Ai Zheng 22(9):968-973, 2003
19. Kondapaka SB, Fridman R, Reddy KB: Epidermal Growth Factor and Amphiregulin up-regulate matrix metalloproteinase-9 (MMP-9) in human breast cancer cells Int J Cancer17(6): 722-726, 1997
20. Ellerbroek SM, Hudson LG, Stack MS: Proteinase requirements of epidermal growth factor induced ovarian cancer cell invasion Int J Cancer78(3)331-337, 1998
21. Ellerbroek SM, HalbleibJM, Benavidez M, WarmkaJK, Wattenberg EV, StackMS, Hudson LG: Phosphatidylinositol 3-kinase activity in epidermal growth factor-stimulated matrix metalloproteinase-9 production and cell surface association. Cancer Res (61): 1855-1861, 2001
22. Huang SM, Li J, Harari PM: Molecular inhibition of angiogenesis and metastatic potential in human squamous cell carcinomas after epidermal growth factor receptor blockade. Mol Cancer Ther 1(7): 507-514, 2002
23. Cox G, Jones JL, O'Byrne KJ: Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer Clin Cancer Res6(6):2349-2355, 2000
24. Liu Z, Klominek J: Inhibition of proliferation, migration, and matrix metalloprotease production in malignant mesothelioma cells by tyrosine kinase inhibitors Neoplasia6(6):705-712, 2004
25. Andreasen PA, Kjoller L, Christensen L, Duffy MJ: The urokinase-type plasminogen activator system in cancer metastasis: A review Int J Cancer 72(1):1-22, 1997
26. Liu D, Aguirre Ghiso J, Estrada Y, Ossowski L: EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma Cancer Cell 1(5):445-457, 2002
27. Aguirre Ghiso JA, Alonso DF, Farias EF, Gomez DE, de Kier Joffe EB: Deregulation of the signaling pathways controlling urokinase production. Its relationship with the invasive phenotype Eur J Biochem 263(2):295-304, 1999
28. Mohanam S, Gladson CL, Rao CN, Rao JS: Biological significance of the expression of urokinase-type plasminogen activator receptors (uPARs) in brain tumors Front Biosci 15(4): D178-D187, 1999
29. Mohanam S, Chintala SK, Go Y, Bhattacharya A, Venkaiah B, Boyd D, Gokaslan ZL, Sawaya R, Rao JS: In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor Oncogene 14(11):1351-1359, 1997
30. Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, Day NE: Dietary effects on breast-cancer risk in Singapore Lancet 337(8751):1197-1200, 1991
31. Persky V, Van Horn L: EpidPmiology of soy and cancer: perspectives and directions J Nutr 125(3):709S-712S, 1995
32. Barnes S, Peterson TG: Biochemical targets of the isoflavone genistein in tumor cell lines Proc Soc Exp Biol Med 208(1):103-108, 1995
33. Fotsis T, Pepper M, Adlercreutz H, Fleischmann G, Hase T, Montesano R, Schweigerer L: Genistein, a dietary-derived inhibitor of in vitro angiogenesis Proc Natl Acad Sci USA90(7):2690-2694, 1993
34. Messina MJ, Persky V, Setchell KD, Barnes S: Soy intake and cancer risk: a review of the in vitro and in vivo data Nutr Cancer 21(2):113-131, 1994
35. Chen WF, Huang MH, Tzang CH, Yang M, Wong MS: Inhibitory actions of genistein in human breast cancer (MCF-7) cells Biochim Biophys Acta 1638(2):187-196, 2003
36. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y: Genistein, a specific inhibitor of tyrosine-specific protein kinases J Biol Chem 262(12):5592-5595, 1987
37. Penar PL, Khoshyomn S, Bhushan A, Tritton TR: Inhibition of epidermal growth factor receptor-associated tyrosine kinase blocks glioblastoma invasion of the brain Neurosurgery 40(1):141-151, 1997
38. Penar PL, Khoshyomn S, Bhushan A, Tritton TR: Inhibition of glioma invasion of fetal brain aggregates In Vivo 12(1):75-84, 1998
39. Lee YS, Seo JS, Chung HT, Jang JJ: Inhibitory effects of biochanin A on mouse lung tumor induced by benzo(a)pyreneJ Korean Med Sci 6(4):325-328, 1991
40. Peterson G, Barnes S: Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation Prostate 22(4):335-345, 1993
41. Hempstock J, Kavanagh JP, George NJ: Growth inhibition of prostate cell lines in vitro by phyto-oestrogens Br J Urol 82(4):560-563, 1998
42. Rice L, Samedi VG, Medrano TA, Sweeney CA, Baker HV, Stenstrom A, Furman J, Shiverick KT: Mechanisms of the growth inhibitory effects of the isoflavonoid biochanin A on LNCaP cells and xenografts Prostate 52(3):201-212, 2002
43. Rao NK, Shi GP, Chapman HA: Urokinase receptor is a multifunctional protein: Influence of receptor occupancy on macrophage gene expression J Clin Invest 96(1):465-474, 1995
44. Laerum OD, Bjerkvig R, Steinsvag SK, de Ridder L: Invasiveness of primary brain tumors Cancer Metastasis Rev 3(3):223-236, 1984
45. Yamamoto S, Sobue T, Kobayashi M, Sasaki S, Tsugane S: Japan Public Health Center-Based Prospective Study on Cancer Cardiovascular Diseases Group. Soy, isoflavones, and breast cancer risk in Japan J Natl Cancer Inst 95(12):906-913, 2003
46. Wu AH, Ziegler RG, Nomura AM, West DW, Kolonel LN, Horn-Ross PL, Hoover RN, Pike MC: Soy intake and risk of breast cancer in Asians and Asian Americans Am J Clin Nutr. 68(6):1437S-1443S, 1998
47. Wu AH, Ziegler RG, Horn-Ross PL, Nomura AM, West DW, Kolonel LN, Rosenthal JF, Hoover RN, Pike MC: Tofu and risk of breast cancer in Asian-Americans Cancer Epidemiol Biomarkers Prev 5(11):901-906, 1996
48. Zheng W, Dai Q, Custer LJ, Shu XO, Wen WQ, Jin F, Franke AA: Urinary excretion of isoflavonoids and the risk of breast cancer Cancer Epidemiol Biomarkers Prev 8(1):35-40, 1999
49. Mikkelsen T, Bjerkvig R, Laerum OD, Rosenblum ML: Brain Tumor Invasion: Biological, Clinical, and Therapeutic Considerations. Wiley-Liss, 1998
50. Kleinman HK, McGarvey ML, Hassell JR, Star VL, Cannon FB, Laurie GW, Martin GR: Basement membrane complexes with biological activity Biochemistry 25(2):312-318, 1986
51. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, McEwan RN: A rapid in vitro assay for quantitating the invasive potential of tumor cells Cancer Res 47(12):3239-3245, 1987
52. Bjerkvig R, Tonnesen A, Laerum OD, Backlund EO: Multicellular tumor spheroids from human gliomas maintained in organ culture J Neurosurg 72(3):463-475, 1990
53. Lund-Johansen M, Bjerkvig R, Humphrey PA, Bigner SH, Bigner DD, Laerum OD: Effect of epidermal growth factor on glioma cell growth, migration, and invasion in vitro Cancer Res 50(18):6039-6044, 1990
54. Lund-Johansen M, Forsberg K, Bjerkvig R, Laerum OD: Effects of growth factors on a human glioma cell line during invasion into rat brain aggregates in culture Acta Neuropathol 84(2):190-197, 1992
55. Yamamoto M, Ueno Y, Hayashi S, Fukushima T: The role of proteolysis in tumor invasiveness in glioblastoma and metastatic brain tumors Anticancer Res 22(6C):4265-4268, 2002
56. Nuttall RK, Pennington CJ, Taplin J, Wheal A, Yong VW, Forsyth PA, Edwards DR: Elevated membrane-type matrix metalloproteinases in gliomas revealed by profiling proteases and inhibitors in human cancer cells Mol Cancer Res 1(5):333-345, 2003
57. Guo P, Imanishi Y, Cackowski FC, Jarzynka MJ, Tao HQ, Nishikawa R, Hirose T, Hu B, Cheng SY: Up-regulation of angiopoietin-2, matrix metalloprotease-2, membrane type 1 metalloprotease, and laminin 5 gamma 2 correlates with the invasiveness of human gliomaAm J Pathol 166(3):877-890, 2005
58. Lakka SS, Gondi CS, Yanamandra N, Dinh DH, Olivero WC, Gujrati M, Rao JS: Synergistic down-regulation of urokinase plasminogen activator receptor and matrix metalloproteinase-9 in SNB19 glioblastoma cells efficiently inhibits glioma cell invasion, angiogenesis, and tumor growth Cancer Res 63(10):2454-2461, 2003
59. Tsatas D, Kaye AH: The role of the plasminogen activation cascade in glioma cell invasion: A review J Clin Neurosci 10(2):139-145, 2003
60. Bhattacharya A, Lakka SS, Mohanam S, Boyd D, Rao JS: Regulation of the urokinase-type plasminogen activator receptor gene in different grades of human glioma cell lines Clin Cancer Res 7(2):267-276, 2001